Matches in Nanopublications for { ?s ?p "[We describe for the first time that high levels of LOXL2 are associated with decreased overall and disease-free survival in laryngeal squamous cell carcinomas, lung squamous cell carcinoma, and lymph node-negative (N(0)) breast adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP534148.RAJl6SmzeZgpSLsqEjmCN_Hpn3k1fNCnWkq3nd-u3osck130_assertion description "[We describe for the first time that high levels of LOXL2 are associated with decreased overall and disease-free survival in laryngeal squamous cell carcinomas, lung squamous cell carcinoma, and lymph node-negative (N(0)) breast adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP534148.RAJl6SmzeZgpSLsqEjmCN_Hpn3k1fNCnWkq3nd-u3osck130_provenance.
- assertion description "[We describe for the first time that high levels of LOXL2 are associated with decreased overall and disease-free survival in laryngeal squamous cell carcinomas, lung squamous cell carcinoma, and lymph node-negative (N(0)) breast adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We describe for the first time that high levels of LOXL2 are associated with decreased overall and disease-free survival in laryngeal squamous cell carcinomas, lung squamous cell carcinoma, and lymph node-negative (N(0)) breast adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP538746.RAkiJn0WUD78WI_ZWmghB_HBzngpjtd74xVTauq6_6NRY130_assertion description "[We describe for the first time that high levels of LOXL2 are associated with decreased overall and disease-free survival in laryngeal squamous cell carcinomas, lung squamous cell carcinoma, and lymph node-negative (N(0)) breast adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538746.RAkiJn0WUD78WI_ZWmghB_HBzngpjtd74xVTauq6_6NRY130_provenance.
- NP538783.RAvzUnfTWabogykVIg5CWvLCBGbGxggNJRW54TAJ5TOeA130_assertion description "[We describe for the first time that high levels of LOXL2 are associated with decreased overall and disease-free survival in laryngeal squamous cell carcinomas, lung squamous cell carcinoma, and lymph node-negative (N(0)) breast adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538783.RAvzUnfTWabogykVIg5CWvLCBGbGxggNJRW54TAJ5TOeA130_provenance.
- NP849159.RAPGgIgmR11b--INYj1rAbwILsU3vz2YgiHj9wfJFMhNU130_assertion description "[We describe for the first time that high levels of LOXL2 are associated with decreased overall and disease-free survival in laryngeal squamous cell carcinomas, lung squamous cell carcinoma, and lymph node-negative (N(0)) breast adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP849159.RAPGgIgmR11b--INYj1rAbwILsU3vz2YgiHj9wfJFMhNU130_provenance.
- NP676942.RA5Bjiw9MJIoygk6NfeEj78k9ho9F5BxqqT_P9oUHotZY130_assertion description "[We describe for the first time that high levels of LOXL2 are associated with decreased overall and disease-free survival in laryngeal squamous cell carcinomas, lung squamous cell carcinoma, and lymph node-negative (N(0)) breast adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP676942.RA5Bjiw9MJIoygk6NfeEj78k9ho9F5BxqqT_P9oUHotZY130_provenance.
- NP676945.RA6Xhj2FlUDvsDnbkgnKZghI3a9wmV_gCDSwVXWu-iGZI130_assertion description "[We describe for the first time that high levels of LOXL2 are associated with decreased overall and disease-free survival in laryngeal squamous cell carcinomas, lung squamous cell carcinoma, and lymph node-negative (N(0)) breast adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP676945.RA6Xhj2FlUDvsDnbkgnKZghI3a9wmV_gCDSwVXWu-iGZI130_provenance.